The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Well I am no expert but when I read the rns both it them with a cup of coffee, I thought what a well balanced rns yes one reason I bought into this share was the technology of the windmills , but they can not finance it so move it on, concentrate on what they believe in Nano technology, they are in talks with a big supplier in farming, that’s good news, seen all this before a rns that people don’t like and a massive drop it happens in SYM to but all will be good eventually, I am in for long term . D y o r .good luck to us long termers and I like the new name also.
Okay this is off topic but I think some people on this board are hoping for a good rise (as I am ) they are looking to move abroad to Spain, I have lived there in the past but returned for family. Here is some new information to help these people. https://www.msn.com/en-gb/news/world/spain-expats-major-rules-for-visas-and-permits-in-post-brexit-blow-fcdo-warning/ar-AAKGicr?li=AAnZ9Ug
Just bought another 2 packs off Amazon I find them comfortable and reassuring that they are killing the virus if in contact.
Good luck lTH we will be rewarded.
Even this should require an update surly.
Pharm 2 Farm Update
The Company is pleased to issue the following update on its wholly owned subsidiary Pharm 2Farm Limited ("P2F").
P2F is continuing to receive enquiries from prospective distributors and purchasers for its viricidal mask and now anticipates that future demand for its mask may outstrip the production line capacity of five million viricidal face masks per month.
To fulfil part of the anticipated excess demand, P2F expects to supply its patented filter material, initially, to certain partner mask manufacturers, until P2F has itself procured additional production lines.
Over the weekend P2F signed binding heads of terms with a manufacturer of surgical masks in Germany. The German manufacturer will subcontract to supply complete masks to P2F to the P2F specification and brand name, and also purchase P2F filter material for their own brand masks. Under the heads of terms the manufacturer will also develop and supply anti-viral C-Fold masks using P2F filter material to extend P2F's market reach. The heads of terms are subject to final contractual agreement between the parties.
The Company will provide further updates to the market as appropriate.
Great posts very informative Thankyou for taking the time .
MyIPA And Wb20.
I know all rns are there to read but after listening to the interview today this helps to understand that they are not in it to be a manufacturer, they licence out there inve
ntions to others .
16 November 2020
Remote Monitored Systems plc ("RMS" or the "Company")
Pharm 2 Farm Update
The Company is pleased to issue the following update on its wholly owned subsidiary Pharm 2Farm Limited ("P2F").
P2F is continuing to receive enquiries from prospective distributors and purchasers for its viricidal mask and now anticipates that future demand for its mask may outstrip the production line capacity of five million viricidal face masks per month.
To fulfil part of the anticipated excess demand, P2F expects to supply its patented filter material, initially, to certain partner mask manufacturers, until P2F has itself procured additional production lines.
Over the weekend P2F signed binding heads of terms with a manufacturer of surgical masks in Germany. The German manufacturer will subcontract to supply complete masks to P2F to the P2F specification and brand name, and also purchase P2F filter material for their own brand masks. Under the heads of terms the manufacturer will also develop and supply anti-viral C-Fold masks using P2F filter material to extend P2F's market reach. The heads of terms are subject to final contractual agreement between the parties.
The Company will provide further updates to the market as appropriate.
ENDS
Well just listened to the interview with Doc and I thought it was very informative, and made me glad I bought the shares I have , it is a long term hold but that’s just fine.
Good morning everyone,
I don’t message much, but enjoy reading most posters on here each day, as a lot of holders here I am well down as bought in at 0.63 , but holding strong as I do believe this company is doing something special in finance, and will rise sharply when good news is released, reading just now that there are just 7.1 per cent of shares that are available to the general public, when this goes boom it will be hard to get in on the action , imho. Take care.
Just read this in INFA web chat,
Don’t RMS have something to do with wind turbines, maybe that’s the small rise.
"Up to 30,000 new jobs are required in the UK steel fabrication sector to build the approximately 300 giant offshore wind turbines each year every year to meet official UK net zero carbon emissions electricity new capacity by 2050."
Well I have just read the RNS and find no reason for such a drop, they are concentrating on the mask, the price as well as the quality, this company will bounce back for sure don’t fall for the price drop. Good luck all let’s see end of day.
Prior to establishing sales channels, it was important to first secure the production pipeline for P2F's ProLarva mask and to clear a few quality-control issues, for which the assistance of Egremont Capital was contracted. As previously reported, the performance of the Lemu mask-making machine has encountered various problems from the outset and the combined teams from P2F and Lemu have been working hard to remedy these issues. The majority of the mechanical concerns have been resolved although issues with the software means the machine is still running significantly below the expected rate. A number of possible solutions have been identified and further progress is expected over the next few weeks.
With the future direction and strategy for P2F now much clearer, the Company is commencing the search for a new Chief Executive Officer.
In the meantime, the immediate focus is on continuing to grow the mask sales and completing the development of a couple of new products in P2F, alongside finalising the consolidated accounts for the RMS Group, which the Company plans to issue around the end of May ahead of holding an AGM around the end of June.
original core field of expertise of agriculture, where increasing the bioavailability of key elements by supplying them as a nano-particle can solve a number of major problems. To these areas can be added the potential for nano-particles in the broader fields of human health and nutrition and also in advanced materials. The Board believes that the long-term value of P2F lies in exploiting these opportunities through the team's ability to produce consistently sized and shaped nano-particles and incorporating them in innovative products.
Good morning everyone, long way to go for me in at 0.63 am £28000 down , so I am jealous of all getting in now I thought mine was a good buy in price could average down but enough in here at present , but like all penny stocks it can turn very quickly , I intend to be Lth anyway so will see what happens in 6-12 months , GLA and be patient with each other.